Indivior share price dives on US court defeat which could hit sales hard February 5, 2019 Pharmaceutical company Indivior’s share price crashed 17 per cent this morning after a US court ruling opened the way for rivals to sell a generic version of its opioid addiction treatment drug in the US. Shares fell from 113p last night to 93p this morning following the decision. The US Court of Appeals for the Federal [...]
Indivior sells China opioid treatment drug as it looks to focus on its core products February 4, 2019 Drug company Indivior has agreed to sell its rights related to the Sai Bo Song (buprenorphine, naloxone) tablet in China to Zhejiang Pukang Biotechnology for $122.5m (£93.6m). The pharmaceutical company said the sale of the tablet was part of its strategy to focus its resources on its core assets and markets. "The divestiture of the [...]
Indivior rallies as it plays rivals at their own game December 18, 2018 Indivior shares jumped over 17 per cent today as the company decided to take on generic copies of its star drug Suboxone by launching a cheaper version. The opioid treatment is facing challenges in the US where it is locked in a court battle with Dr Reddy’s Laboratories (DRL). Last week Indivior won a case [...]
Indivior shares crash as US Court of Appeal overturns drug ruling November 21, 2018 FTSE 250 pharma giant Indivior saw its share price plunge more than 10 per cent in early morning trading, after a court ruling against the drug maker last night rocked investor confidence. The US Court of Appeal yesterday decided that a generic drug company, Dr Reddy’s Laboraties, would be allowed to sell a copycat version [...]
Indivior shares plunge as firm reduces full-year sales guidance September 27, 2018 Shares in addiction treatment pharma firm Indivior took a eight per cent hit this morning after it said sales for the year would be lower than expected. Indivior on Wednesday said full-year sales would be revised down to between $990m (£755m) and $1.02bn (£780m) from its February estimate of between $1.13bn and $1.17bn. In particular, it [...]
Indivior share price hit as US rivals hurt profits February 11, 2015 Shares at Indivior crumbled during yesterday’s trade but recovered to be down only 2.4 per cent. The FTSE-listed company which specialises in the production of Suboxone, a substitute used by recovering heroin addicts, was spun off last December from Reckitt Benckiser – the Slough-based health giant whose brands range from Dettol to Durex. The company [...]